FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


141007 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
Azerbaijan Zebu cattle breed Moved elsewhere
Azerbaijan horse breed Moved elsewhere
Azithromycin - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azithromycin 1% ophthalmic solution A component that is no longer current, useful, appropriate or acceptable.
Azithromycin 100mg/5mL oral suspension A component that is no longer current, useful, appropriate or acceptable.
Azithromycin 1g/packet oral A component that fails to comply with the current editorial guidance.
Azithromycin 250mg tablet A component that is no longer current, useful, appropriate or acceptable.
Azithromycin 2g/60mL microspheres for oral suspension A component that is no longer current, useful, appropriate or acceptable.
Azithromycin 600mg tablet A component that is no longer current, useful, appropriate or acceptable.
Azithromycin dihydrate 100mg/5mL suspension A component that is no longer current, useful, appropriate or acceptable.
Azithromycin dihydrate 100mg/mL powder A component that fails to comply with the current editorial guidance.
Azithromycin dihydrate 1200mg suspension A component that fails to comply with the current editorial guidance.
Azithromycin dihydrate 1g suspension A component that fails to comply with the current editorial guidance.
Azithromycin dihydrate 200mg/ 5 mL suspension A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azithromycin dihydrate 200mg/5 mL powder A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azithromycin dihydrate 200mg/5 mL suspension A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azithromycin dihydrate 200mg/5mL suspension A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azithromycin dihydrate 250mg capsule A component that is no longer current, useful, appropriate or acceptable.
Azithromycin overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azithromycin poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azlocillin - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azlocillin sodium - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azo dyes A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azo-Sulfamethoxazole A component that fails to comply with the current editorial guidance.
Azoospermia A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azoospermia A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azoospermia A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Azoospermia due to chemotherapy AND/OR radiation Ambiguous
Azores horse breed Moved elsewhere
Azospirillum species Ambiguous
Aztec A component that fails to comply with the current editorial guidance.
Azteca horse breed Moved elsewhere
Aztreonam - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Aztreonam 20mg/mL injection solution 50mL plastic container A component that fails to comply with the current editorial guidance.
Aztreonam 40mg/mL injection solution 50mL plastic container A component that fails to comply with the current editorial guidance.
Aztreonam 75mg powder for nebulizer solution A component that is no longer current, useful, appropriate or acceptable.
Azure flycatcher Ambiguous
Azygos vein and its tributaries Ambiguous
Azygos venogram A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B Ambiguous
B COMPLEX ONE-FIFTY Moved elsewhere
B COMPLEX ONE-FIFTY INJECTION Moved elsewhere
B COMPLEX WITH C AND B-12 INJECTION Moved elsewhere
B lymphoblastic leukemia / lymphoma - category A component that is no longer current, useful, appropriate or acceptable.
B lymphoblastic leukemia lymphoma, no International Classification of Diseases for Oncology subtype A component that is no longer current, useful, appropriate or acceptable.
B-K mole (nevus) syndrome Ambiguous
B-cell chronic lymphocytic leukemia A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B-cell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B-cell lymphoma with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B1 VAC Moved elsewhere
B12 deficiency - dubious diagnostic criteria A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B12 deficiency anaemia (& other) A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B12 deficiency anaemia (& other) Ambiguous
B12 deficiency follow-up assessment A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B12 deficiency initial assessment A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B12 deficiency monitoring A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B12 deficiency monitoring NOS Classification derived component
B12 deficiency monitoring NOS Classification derived component
B12 injections - at home A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B12 injections - at surgery A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B12 injections started A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B12 injections stopped A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B12/folate level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
B12/folate level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
BAAF Adult 1 - fee to referral agency A component that fails to comply with the current editorial guidance.
BAAF Adult 1-fee paid A component that fails to comply with the current editorial guidance.
BAAF Adult 1-fee to patient A component that fails to comply with the current editorial guidance.
BAAF Adult 1-fee unpaid A component that fails to comply with the current editorial guidance.
BAAF Adult 1/2 NOS A component that fails to comply with the current editorial guidance.
BAAF Adult 2 - fee to referral agency A component that fails to comply with the current editorial guidance.
BAAF Adult 2-fee paid A component that fails to comply with the current editorial guidance.
BAAF Adult 2-fee to patient A component that fails to comply with the current editorial guidance.
BAAF Adult 2-fee unpaid Moved elsewhere
BAAF B1-fee paid A component that fails to comply with the current editorial guidance.
BAAF B1-fee sent to SS A component that fails to comply with the current editorial guidance.
BAAF B1-fee to adopt agency A component that fails to comply with the current editorial guidance.
BAAF B1-fee unpaid A component that fails to comply with the current editorial guidance.
BAAF B1-obstetric report sent Moved elsewhere
BAAF B1/2 - NOS Moved elsewhere
BAAF B1/2 - adoption: birth history A component that fails to comply with the current editorial guidance.
BAAF B2-fee paid A component that fails to comply with the current editorial guidance.
BAAF B2-fee sent to SS Meaning of component unknown (foundation metadata concept)
BAAF B2-fee to adopt agency A component that fails to comply with the current editorial guidance.
BAAF B2-fee unpaid A component that fails to comply with the current editorial guidance.
BAAF B2-neonatal report sent Moved elsewhere
BAAF C-infant report sent Moved elsewhere
BAAF C/D - NOS Moved elsewhere
BAAF C/D - fee paid Moved elsewhere
BAAF C/D - fee sent to SS Moved elsewhere
BAAF C/D - fee to adoption agency Moved elsewhere
BAAF C/D - fee unpaid Moved elsewhere
BAAF C/D-adopt:child report A component that fails to comply with the current editorial guidance.
BAAF D-child 2+yrs rep sent A component that fails to comply with the current editorial guidance.
BACIFERM 50 Moved elsewhere
BACITRACIN -NEOMYCIN-POLYMYXIN OINTMENT Moved elsewhere
BACITRACIN -NEOMYCIN-POLYMYXIN-HYDROCORTISONE ACETATE 1% Moved elsewhere
BACTO-SEP Moved elsewhere
BACTODERM Moved elsewhere
BACTROVET ORAL SUSPENSION Moved elsewhere
BACTROVET TABLETS Moved elsewhere
BALANCE PREPARATION Moved elsewhere

Start Previous Page 145 of 1411 Next End


Reference Sets

Reference set descriptor

Back to Start